CLIMB BIO INC (CLYM) Stock Income Statement
USA - NASDAQ:CLYM - US28658R1068 - Common Stock
2.25 USD
-0.07 (-3.02%)
2.25 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 52.98M | 27.00M | 21.47M | 45.14M | 35.67M | |||
| Research and Development | 33.38M | 11.61M | 11.58M | 26.21M | 23.32M | |||
| Selling, General, and Administrative Expenses | 19.60M | 15.39M | 9.89M | 18.92M | 12.35M | |||
| Operating Income | -52.98M | -27.00M | -21.47M | -45.14M | -35.67M | |||
| Interest Income/Expense | 9.58M | 8.12M | 5.16M | -1.48M | -170.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 1.38M | -11.64M | |||
| Non Recurring Items | N/A | -55.02M | -18.81M | N/A | N/A | |||
| Income Before Taxes | -46.76M | -73.90M | -35.12M | -45.24M | -47.48M | |||
| Net Income | -46.76M | -73.90M | -35.12M | -45.24M | -52.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.69 | -1.53 | -1.30 | -1.72 | -4.24 | |||
| Non GAAP EPS | N/A | N/A | N/A | -1.72 | N/A | |||
| Statistics | ||||||||
All data in USD